COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,899 Articles (22,568 medRxiv, 8,331 bioRxiv)

Most recent first Previous |  Page 2370: Articles 23691-23700  | Next

Forecasting COVID-19: Using SEIR-D quantitative modelling for healthcare demand and capacity
Campillo-Funollet, E., Van Yperen, J., Allman, P., Bell, M., Beresford, W., Clay, J., Evans, G., Dorey, M., Gilchrist, K., Gurprit, P., Walkley, R., Watson, M., Madzvamuse, A.
10.1101/2020.07.29.20164566 — Posted: 2020-08-01
Estimating the total size of coronavirus epidemic in Algeria via different approaches
REZKI, M.
10.1101/2020.07.29.20164509 — Posted: 2020-08-01
Modeling latent infection transmissions through biosocial stochastic dynamics
Tadic, B., Melnik, R.
10.1101/2020.07.30.20164491 — Posted: 2020-08-01
Clinical Outcomes From COVID-19 Following Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers Among Patients with Hypertension in South Korea: A nationwide study
Kim, J. H., Baek, Y.-H., Lee, H., Choe, Y. J., Shin, H. J., Shin, J.-Y.
10.1101/2020.07.29.20164822 — Posted: 2020-08-01
Rapid real-time tracking of non-pharmaceutical interventions and their association SARS-CoV-2 positivity: The COVID-19 Pandemic Pulse Study
Clipman, S. J., Wesolowski, A. P., Gibson, D. G., Agarwal, S., Lambrou, A. S., Kirk, G. D., Labrique, A. B., Mehta, S. H., Solomon, S. S.
10.1101/2020.07.29.20164665 — Posted: 2020-08-01 Discussion: Offsite
SABCoM: A Spatial Agent-Based Covid-19 Model
Davids, A., Rand, G. D., Georg, C.-P., Koziol, T., Schasfoort, J. A.
10.1101/2020.07.30.20164855 — Posted: 2020-08-01
Whether the Weather Will Help Us Weather the COVID-19 Pandemic: Using Machine Learning to Measure Twitter Users' Perceptions
Gupta, M., Bansal, A., Jain, B., Rochelle, J., Oak, A., Jalali, M. S.
10.1101/2020.07.29.20164814 — Posted: 2020-08-01
Sex-specificity of mortality risk factors among hospitalized COVID-19 patients in New York City: prospective cohort study
Jun, T., Nirenberg, S., Kovatch, P., Huang, K.-l.
10.1101/2020.07.29.20164640 — Posted: 2020-08-01
Loss expansion of SARS-CoV-2 specific immunity is a key risk factor in fatal patients with COVID-19
Zeng, Q., Huang, G., Li, Y.-z., Xu, G., Dong, S.-y., Zhong, T.-y., Chen, Z.-t., Xu, Y.
10.1101/2020.07.29.20164681 — Posted: 2020-08-01 Discussion: Onsite | Offsite
Throat wash as a source of SARS-CoV-2 RNA to monitor community spread of COVID-19.
Lopez-Lopes, G. I. S., Ahagon, C. M., Bonega, M. A., Santos, F. P. d., Santos, K. C. d. O., Cilli, A., Prado, L. S. d., Silva, D. B. B. d., Luz, N. B. d., Saraceni, C. P., Afonso, A. M. S., Timenetsky, M. d. C., Brigido, L. F. d. M.
10.1101/2020.07.29.20163998 — Posted: 2020-08-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).